FDA Unveils Risk-Based Enforcement Approach to Homeopathic Drugs Post author:Sam Post published:December 19, 2017 Post category:Drug Industry Daily In a new policy initiative, the FDA outlined new enforcement measures for homeopathic products. Source: Drug Industry Daily You Might Also Like Indian API Manufacturer Called Out for Numerous Violations June 18, 2018 Jazz Pharma Sues FDA, Claiming Approval of Avadel’s Narcolepsy Drug is Unlawful June 23, 2023 Patient Death Prompts Pause in Atara’s Mesothelioma CAR-T Cell Study February 18, 2022